Provided by Tiger Trade Technology Pte. Ltd.

Personalis

17.07
+0.27001.61%
Pre-market: 17.140.0700+0.41%08:37 EDT
Volume:2.97M
Turnover:50.30M
Market Cap:1.83B
PE:-15.55
High:17.24
Open:16.75
Low:16.60
Close:16.80
52wk High:18.89
52wk Low:4.67
Shares:107.00M
Float Shares:72.63M
Volume Ratio:0.65
T/O Rate:4.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-0.9107
ROE:-50.32%
ROA:-25.03%
PB:7.77
PE(LYR):-18.74

Loading ...

Personalis Q2 Net Income USD -31.683 Million

Reuters
·
Aug 05

Personalis Q2 Revenue USD 22.357 Million VS. Ibes Estimate USD 16.8 Million

THOMSON REUTERS
·
Aug 05

Personalis Q2 Basic EPS USD -0.3

THOMSON REUTERS
·
Aug 05

Personalis Inc Expected to Post a Loss of 26 Cents a Share - Earnings Preview

Reuters
·
Jul 31

Legal Firms Probe Personalis Acquisition Deal for Shareholder Fairness

Deep News
·
Jul 22

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Benzinga_recent_news
·
Jul 22

Danaher Q2 Revenue, Adjusted EPS Beats on Life Sciences Segment Strength; Raises Outlook

Reuters
·
Jul 21

Personalis Inc : Needham Cuts to Hold from Buy

THOMSON REUTERS
·
Jul 21

Personalis Acquisition Price Warranted by Growth Prospects, Needham Says

MT Newswires Live
·
Jul 21

Morgan Stanley sees strategic logic in Personalis deal despite financial hurdles

TIPRANKS
·
Jul 21

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

TIPRANKS
·
Jul 21

Top Midday Decliners

MT Newswires Live
·
Jul 21

Midday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis

TIPRANKS
·
Jul 21

Needham Downgrades Personalis to Hold From Buy

MT Newswires Live
·
Jul 20

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Personalis (PSNL) and PTC Therapeutics (PTCT)

TIPRANKS
·
Jul 20

Personalis Cut to Hold from Buy by Needham

Dow Jones
·
Jul 20

Personalis downgraded to Hold from Buy at Needham

TIPRANKS
·
Jul 20

Personalis downgraded to Hold from Buy at Lake Street

TIPRANKS
·
Jul 20

Personalis to be acquired by Tempus AI in merger

TIPRANKS
·
Jul 20

Tempus Publishes Investor Deck on Planned Personalis Acquisition to Expand MRD Testing Platform

Reuters
·
Jul 20